Trials / Completed
CompletedNCT04816253
Controlling Post-extraction Complications of Impacted Mandibular Third Molar
Methylprednisolone and Hyaluronic Acid Versus Each Agent Alone to Control Post-extraction Complications of Impacted Mandibular Third Molar
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Al-Azhar University · Academic / Other
- Sex
- All
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
Impacted mandibular 3rd molar will be extracted in all patients, then patients will be divided, according to material placed in extraction socket into 3 groups: control, hyaluronic acid and honey. Then post extraction complications will be evaluated
Detailed description
Impacted Mandibular third molar will be extracted under local anesthesia Through standard surgical flap elevation, after extraction and wound irrigation a material facilitate healing will be placed. According to material will be placed patients will be divide into 3 group: control ( no material, second group hyaluronic acid, third group ( honey).. then wound will be closed. Postoperative pain ( through visual analog scale) , edema, total dose of analgesic, mandibular movement (interincisal distance in mm) will be evaluated preoperative, 1,2,3,7, and 10 day after extraction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Normal saline | Normal saline irrigation and No other drug placed after extraction |
| DRUG | Hyaluronic acid | Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket |
| DRUG | Methylprednisolone | Methylprednsolone will be injected half an hour preoperatively |
| DRUG | Methylprednisolone and Hyaluronic acid | Methylprednisolone will be injected half an hour preoperatively and Immediately after removal of impacted tooth (hyaluronic acid) placed in extraction socket |
Timeline
- Start date
- 2021-02-10
- Primary completion
- 2021-06-20
- Completion
- 2021-06-20
- First posted
- 2021-03-25
- Last updated
- 2021-07-22
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT04816253. Inclusion in this directory is not an endorsement.